Northwestern Mutual Wealth Management
ALDR

Northwestern Mutual Wealth Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-20
Closed – – 2567
2016
Q4 		$0 Buy
+20
New +$520 ﹤0.01% 2403

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Northwestern Mutual Wealth Management's ALDR Position: Q1 2017 in Review

Northwestern Mutual Wealth Management sold out of Alder Biopharmaceuticals (ALDR) in Q1 2017, closing a stake of 20 shares.

Northwestern Mutual Wealth Management first reported a position in ALDR in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 142 funds tracked by Wall St. Rank hold ALDR as of Q1 2017.

  • Northwestern Mutual Wealth Management reported no remaining Alder Biopharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 20 Alder Biopharmaceuticals shares in Q1 2017.
  • Northwestern Mutual Wealth Management first reported a position in Alder Biopharmaceuticals in Q4 2016 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Alder Biopharmaceuticals position peaked at $0 in Q4 2016.
  • 142 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2017.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.